Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

ESTUDIOS


01 enero 2012

AMERICAN JOURNAL OF NEURORADIOLOGY. Carotid Atherosclerotic Plaque Progression and Change in Plaque Composition Over Time: A 5-Year Follow-Up Study Using Serial CT Angiography

M.J. van Gils, D. Vukadinovic, A.C. van Dijk, D.W.J. Dippel, W.J. Niessen and A. van der Lugt

BACKGROUND AND PURPOSE: Serial in vivo imaging of atherosclerosis is important for understanding plaque progression and is potentially useful in predicting cardiovascular events and monitoring treatment efficacy. This prospective study aims to quantify temporal changes in carotid atherosclerotic plaque volume and plaque composition using MDCTA.

01 febrero 2012

AMERICAN JOURNAL OF NEURORADIOLOGY. Classification of Cerebral Arteriovenous Malformations and Intranidal Flow Patterns by Color-Encoded 4D-Hybrid-MRA

T. Illies, N.D. Forkert, T. Ries, J. Regelsberger and J. Fiehler

BACKGROUND AND PURPOSE: 4D MRA has been evolving as a noninvasive supplement for DSA. The purpose of this study was to evaluate the feasibility of a newly developed blood flow visualization technique for the classification of cerebral AVMs. We hypothesized that 4D-hMRA allows detection of different flow patterns within the nidus as well as differentiation of feeders and draining veins and has very good agreement with DSA regarding the Spetzler-Martin grade.

01 agosto 2012

AMERICAN JOURNAL OF NEURORADIOLOGY. Endovascular Reconstruction for Treatment of Vertebrobasilar Dolichoectasia: Long-Term Outcomes

X. Wua, Y. Xu, B. Hong, W.-Y. Zhao, Q.-H. Huang and J.-M. Liu

BACKGROUND AND PURPOSE: VBD can trigger various clinical symptoms, especially ischemic stroke in the posterior circulation, but there is no effective treatment for their prevention. We aimed to validate the feasibility of coil-assisted stent reconstruction in the vascular lumen for the treatment of VBD and to evaluate its long-term effectiveness in preventing ischemic events.

01 enero 2012

AMERICAN JOURNAL OF NEURORADIOLOGY. Endovascular Treatment of Ruptured Brain AVMs in the Acute Phase of Hemorrhage

W.J. van Rooija, S. Jacobs, M. Sluzewski, G.N. Beute and B. van der Pol

BACKGROUND AND PURPOSE: Patients with ruptured brain AVMs are at considerable risk of repeat hemorrhage, particularly when associated intranidal or flow-related aneurysms are present. There is controversy about the timing of diagnosis and treatment of patients with hemorrhagic stroke. We present our results of endovascular treatment of ruptured AVMs in the acute phase.

01 abril 2012

AMERICAN JOURNAL OF NEURORADIOLOGY. Curative Embolization of Brain Arteriovenous Malformations with Onyx: Patient Selection, Embolization Technique, and Results

W.J. van Rooij, S. Jacobs, M. Sluzewski, B. van der Pol, G.N. Beute and M.E. Sprengers

BACKGROUND AND PURPOSE: A new curative embolization technique with Onyx for selected small and medium-sized superficially located brain AVMs was developed, which consists of obliteration of the nidus, including incremental occlusion of the draining veins. We report our first clinical results.

01 abril 2012

AMERICAN JOURNAL OF NEURORADIOLOGY. Local Thrombolysis for Severe Cerebral Venous Sinus Thrombosis

X.-b. Guo, S. Guan, Y. Fan and L.-j. Song

BACKGROUND AND PURPOSE: Cerebral venous thrombosis is a rare entity that can be difficult to manage. Most patients with cerebral sinus thrombosis recover after treatment with heparin, but a subgroup of severe cerebral venous sinus thrombosis has a poor prognosis. Those patients may benefit from intrasinus thrombolysis. The purpose of this research was to carry out a retrospective analysis of patients with severe cerebral venous sinus thrombosis, and to study the safety and efficacy of intrasinus thrombolysis in patients with cerebral venous sinus thrombosis unresponsive to conventional heparin therapy.

01 abril 2012

AMERICAN JOURNAL OF NEURORADIOLOGY. Vascular Wall Imaging of Vulnerable Atherosclerotic Carotid Plaques: Current State of the Art and Potential Future of Endovascular Optical Coherence Tomography

B.A. Standish, J. Spears, T.R. Marotta, W. Montaner and V.X.D. Yang

SUMMARY: As stroke is one of the leading causes of death and long-term morbidity worldwide, the research community has studied cardiac embolic sources, as well as vessel wall pathologies. For the latter, attention has been focused on defining morphologic tissue features associated with catastrophic events stemming from the carotid artery. Multiple noninvasive imaging modalities are currently being used to image and classify carotid atherosclerotic plaques, such as MR imaging, CT, and sonography, in an effort to provide clinically relevant predictive metrics for use in patient risk stratification and to define appropriate treatment options. This article compares and contrasts these existing clinical imaging modalities along with discussion of a new endovascular technique originally developed for cardiology, OCT, with which 3D comprehensive high-resolution images of the arterial wall can be acquired.

01 noviembre 2011

AMERICAN JOURNAL OF NEURORADIOLOGY. Cervical and Lumbar Spinal Arthroplasty: Clinical Review

T.D. Uschold, D. Fusco, R. Germain, L.M. Tumialan and S.W. Chang

SUMMARY: In contrast to cervical and lumbar fusion procedures, the principal aim of disk arthroplasty is to recapitulate the normal kinematics and biomechanics of the spinal segment affected. Following decompression of the neural elements, disk arthroplasty allows restoration of disk height and maintenance of spinal alignment. Based on clinical observations and biomechanical testing, the anticipated advantage of arthroplasty over standard arthrodesis techniques has been a proposed reduction in the development of symptomatic ALD. In this review of cervical and lumbar disk arthroplasty, we highlight the clinical results and experience with standard fusion techniques, incidence of ALD in the population of patients with surgical fusion, and indications for arthroplasty, as well as the biomechanical and clinical outcomes following arthroplasty. In addition, we introduce the devices currently available and provide a critical appraisal of the clinical evidence regarding arthroplasty procedures.

01 marzo 2012

AMERICAN JOURNAL OF NEURORADIOLOGY. Flow-Diverter Silk Stent for the Treatment of Intracranial Aneurysms: 1-year Follow-Up in a Multicenter Study

J. Berge, A. Biondi, P. Machc, H. Brunel, L. Pierot, J. Gabrillarguesf, K. Kadziolka, X. Barreau, V. Dousset and A. Bonafé

BACKGROUND AND PURPOSE: FD stent placement is a promising therapy for challenging intracranial aneurysms. Long-term evaluations about angiographic and morphologic results are still missing. This is the aim of this multicenter series.

01 julio 2012

AMERICAN JOURNAL OF NEURORADIOLOGY. Intrasaccular Flow-Disruption Treatment of Intracranial Aneurysms: Preliminary Results of a Multicenter Clinical Study

L. Pierot, T. Liebig, V. Sychra, K. Kadziolka, F. Dorn, C. Strasill, C. Kabbasch and J. Klisch

BACKGROUND AND PURPOSE: The endovascular treatment of intracranial aneurysms with unfavorable anatomy (large aneurysms, wide-neck) is frequently challenging and is also associated with a high incidence of significant recurrences. The WEB, an intrasaccular flow disrupter, was designed for use in this type of aneurysm. We report our early experience with this device in this multicenter study.

01 enero 2012

AMERICAN JOURNAL OF NEURORADIOLOGY. Intracranial Dural Arteriovenous Fistulas: Classification, Imaging Findings, and Treatment

D. Gandhi, J. Chen, M. Pearl, J. Huang, J.J. Gemmete and S. Kathuria

SUMMARY: Intracranial DAVFs are pathologic dural-based shunts and account for 10%–15% of all intracranial arteriovenous malformations. These malformations derive their arterial supply primarily from meningeal vessels, and the venous drainage is either via dural venous sinuses or through the cortical veins. DAVFs have a reported association with dural sinus thrombosis, venous hypertension, previous craniotomy, and trauma, though many lesions are idiopathic. The diagnosis is dependent on a high level of clinical suspicion and high-resolution imaging. Cross-sectional imaging techniques by using CT and MR imaging aid in the diagnosis, but conventional angiography remains the most accurate method for complete characterization and classification of DAVFs. The pattern of venous drainage observed on dynamic vascular imaging determines the type of DAVF and correlates with the severity of symptoms and the risk of hemorrhage.

01 junio 2013

JACC. N-Terminal Pro–B-Type Natriuretic Peptide for Risk Assessment in Patients With Atrial FibrillationInsights From the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation)

Ziad Hijazi, MD; Lars Wallentin, MD, PhD; Agneta Siegbahn, MD, PhD; Ulrika Andersson, MSc; Christina Christersson, MD, PhD; Justin Ezekowitz, MBBCh, MSc; Bernard J. Gersh, MD; Michael Hanna, MD; Stefan Hohnloser, MD; John Horowitz, MD; Kurt Huber, MD; Elaine M. Hylek, MD, MPH; Renato D. Lopes, MD, PhD; John J.V. McMurray, MD; Christopher B. Granger, MD

Objectives: This study sought to assess the prognostic value of N-terminal pro–B-type natriuretic peptide (NT-proBNP) in patients with atrial fibrillation (AF) enrolled in the ARISTOTLE (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation) trial, and the treatment effect of apixaban according to NT-proBNP levels.

01 mayo 2013

STROKE. Reimbursement for Thrombectomy Devices in Patients Who Are Ineligible for Intravenous Tissue-Type Plasminogen Activator

Joseph P. Broderick, MD; Thomas A. Tomsick, MD, for the Interventional Management of Stroke (IMS) III Executive Committee

Intravenous tissue-type plasminogen activator (t-PA) is an effective treatment for acute ischemic stroke for which efficacy is very time dependent and its greatest benefit occurs with early treatment.1 Not all patients with ischemic stroke who arrive within 2 to 3 hours after stroke onset are eligible for IV t-PA because they have contraindications, such as recent major surgery, ongoing anticoagulation at the time of stroke, etc.2 These t-PA–ineligible patients with moderate and severe strokes are often treated with intra-arterial t-PA via an endovascular procedure and, more recently, thrombectomy devices. Moreover, a sizable proportion of patients with moderate to severe stroke who do receive IV t-PA still have a poor outcome because IV t-PA was unable to lyse the clot or did so after the brain was irreversibly destined for infarction.1,3 Thus, there is a great need for more rapid and effective approaches to reperfusion.

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.